These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27990160)

  • 1. The Roles of PI3K/AKT/mTOR and MAPK/ERK Signaling Pathways in Human Pheochromocytomas.
    Du J; Tong A; Wang F; Cui Y; Li C; Zhang Y; Yan Z
    Int J Endocrinol; 2016; 2016():5286972. PubMed ID: 27990160
    [No Abstract]   [Full Text] [Related]  

  • 2. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.
    Gedaly R; Angulo P; Hundley J; Daily MF; Chen C; Evers BM
    J Surg Res; 2012 Aug; 176(2):542-8. PubMed ID: 22261591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-after-high glucose down-regulated Cx43 in H9c2 cells by autophagy activation via cross-regulation by the PI3K/Akt/mTOR and MEK/ERK
    Bi Y; Wang G; Liu X; Wei M; Zhang Q
    Endocrine; 2017 May; 56(2):336-345. PubMed ID: 28181145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison between dual inhibition of mTOR with MAPK and PI3K signaling pathways in KRAS mutant NSCLC cell lines.
    Dogan Turacli I; Ozkan AC; Ekmekci A
    Tumour Biol; 2015 Dec; 36(12):9339-45. PubMed ID: 26108998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K/AKT/mTOR signaling pathway inhibitors in proliferation of retinal pigment epithelial cells.
    Cai N; Dai SD; Liu NN; Liu LM; Zhao N; Chen L
    Int J Ophthalmol; 2012; 5(6):675-80. PubMed ID: 23275900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells.
    Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z
    Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ERK1/2 and mTORC1 Signaling Pathways Are Involved in the Muscarinic Acetylcholine Receptor-Mediated Proliferation of SNU-407 Colon Cancer Cells.
    Park YS; Liu Z; Vasamsetti BM; Cho NJ
    J Cell Biochem; 2016 Dec; 117(12):2854-2863. PubMed ID: 27167250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Dose Radiation Induces Cell Proliferation in Human Embryonic Lung Fibroblasts but not in Lung Cancer Cells: Importance of ERK1/2 and AKT Signaling Pathways.
    Liang X; Gu J; Yu D; Wang G; Zhou L; Zhang X; Zhao Y; Chen X; Zheng S; Liu Q; Cai L; Cui J; Li W
    Dose Response; 2016; 14(1):1559325815622174. PubMed ID: 26788032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platycodin-D Induced Autophagy in Non-Small Cell Lung Cancer Cells via PI3K/Akt/mTOR and MAPK Signaling Pathways.
    Zhao R; Chen M; Jiang Z; Zhao F; Xi B; Zhang X; Fu H; Zhou K
    J Cancer; 2015; 6(7):623-31. PubMed ID: 26078792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3K pathway is involved in ERK signaling cascade activation by histamine H2R agonist in HEK293T cells.
    Alonso N; Diaz Nebreda A; Monczor F; Gutkind JS; Davio C; Fernandez N; Shayo C
    Biochim Biophys Acta; 2016 Sep; 1860(9):1998-2007. PubMed ID: 27316323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CK-3, A Novel Methsulfonyl Pyridine Derivative, Suppresses Hepatocellular Carcinoma Proliferation and Invasion by Blocking the PI3K/AKT/mTOR and MAPK/ERK Pathways.
    Wu Q; Liu TY; Hu BC; Li X; Wu YT; Sun XT; Jiang XW; Wang S; Qin XC; Ding HW; Zhao QC
    Front Oncol; 2021; 11():717626. PubMed ID: 34395292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation.
    Huang S; Zhang A; Ding G; Chen R
    Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1323-33. PubMed ID: 19339632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic anticancer efficacy of MEK inhibition and dual PI3K/mTOR inhibition in castration-resistant prostate cancer.
    Park H; Kim Y; Sul JW; Jeong IG; Yi HJ; Ahn JB; Kang JS; Yun J; Hwang JJ; Kim CS
    Prostate; 2015 Nov; 75(15):1747-59. PubMed ID: 26250606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways.
    Campbell M; Allen WE; Sawyer C; Vanhaesebroeck B; Trimble ER
    Circ Res; 2004 Aug; 95(4):380-8. PubMed ID: 15242975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylethanolamine-binding protein 4 promotes lung cancer cells proliferation and invasion via PI3K/Akt/mTOR axis.
    Yu G; Huang B; Chen G; Mi Y
    J Thorac Dis; 2015 Oct; 7(10):1806-16. PubMed ID: 26623104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma.
    Kim MN; Lee SM; Kim JS; Hwang SG
    Cancer Chemother Pharmacol; 2019 Oct; 84(4):809-817. PubMed ID: 31385002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade.
    Penna I; Molla A; Grazia G; Cleris L; Nicolini G; Perrone F; Picciani B; Del Vecchio M; de Braud F; Mortarini R; Anichini A
    Oncotarget; 2016 Jan; 7(4):3947-65. PubMed ID: 26678033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.